Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

77 та иш

Иш: Liposomes containing histidine overcome poly ADP-ribose polymerase inhibitor resistance

  1. The blockade of immune checkpoints in cancer immunotherapy

    Drew M. Pardoll

    Шарҳ мақола20127 иқтибос
    ABI
  2. On the Origin of Cancer Cells

    Otto Warbürg

    Мақола19566 иқтибос
    ABI
  3. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

    Padmanee Sharma, Siwen Hu‐Lieskovan, Jennifer A. Wargo +1

    Шарҳ мақола20173 иқтибос
    ABI
  4. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

    Kai Kessenbrock, Vicki Plaks, Zena Werb

    Шарҳ мақола20102 иқтибос
    ABI
  5. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

    Hannah Farmer, Nuala McCabe, Christopher J. Lord +11

    Мақола20052 иқтибос
    ABI
  6. PARP inhibitors: Synthetic lethality in the clinic

    Christopher J. Lord, Alan Ashworth

    Шарҳ мақола20172 иқтибос
    ABI
  7. Poly(ADP-ribose) polymerase inhibition: past, present and future

    Nicola J. Curtin, Csaba Szabó

    Шарҳ мақола20202 иқтибос
    ABI
  8. Transcriptional regulation of macrophage polarization: enabling diversity with identity

    Toby Lawrence, Gioacchino Natoli

    Шарҳ мақола20112 иқтибос
    ABI
  9. Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines

    Peter J. Murray, Judith E. Allen, Subhra K. Biswas +22

    Мақола20142 иқтибос
    ABI
  10. Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer

    Talia Golan, Pascal Hammel, Michele Reni +16

    Мақола20192 иқтибос
    ABI
  11. Resistance to therapy caused by intragenic deletion in BRCA2

    Stacey L. Edwards, Rachel Brough, Christopher J. Lord +6

    Мақола20082 иқтибос
    ABI
  12. From Krebs to clinic: glutamine metabolism to cancer therapy

    Brian J. Altman, Zachary E. Stine, Chi V. Dang

    Шарҳ мақола20162 иқтибос
    ABI
  13. The landscape of somatic copy-number alteration across human cancers

    Rameen Beroukhim, Craig H. Mermel, Dale Porter +59

    Мақола20102 иқтибос
    ABI
  14. Histidine catabolism is a major determinant of methotrexate sensitivity

    Naama Kanarek, Heather R. Keys, Jason R. Cantor +7

    Мақола20182 иқтибос
    ABI
  15. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI
  16. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI
  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI
  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI
  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI
  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI
  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI